Protara Therapeutics, Inc.
TARA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001359931
In the last 90 days, Protara Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 119 institutions reported holding it in 13F filings for Q2 2026, worth $176.0M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Protara Therapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 29
- −1 vs. Q4 2022
- Shares held
- 5.50M
- +25.0K (+0.5%) vs. Q4 2022
- Total value
- $16.9M
- +$2.21M (+15.0%) vs. Q4 2022
- New holders
- 2
- 5 more added
- Sold out
- 3
- 6 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TARA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 119 | $176.0M |
| Q1 2026 | 114 | $237.4M |
| Q4 2025 | 105 | $212.3M |
| Q3 2025 | 81 | $114.0M |
| Q2 2025 | 76 | $90.1M |
| Q1 2025 | 59 | $123.8M |
| Q4 2024 | 60 | $156.6M |
| Q3 2024 | 35 | $19.1M |
| Q2 2024 | 38 | $22.2M |
| Q1 2024 | 34 | $18.3M |
| Q4 2023 | 30 | $8.17M |
| Q3 2023 | 31 | $8.55M |
| Q2 2023 | 29 | $12.3M |
| Q1 2023 | 29 | $16.9M |
| Q4 2022 | 30 | $14.7M |
| Q3 2022 | 31 | $16.7M |
| Q2 2022 | 33 | $18.4M |
| Q1 2022 | 35 | $33.2M |
| Q4 2021 | 38 | $46.5M |
| Q3 2021 | 36 | $43.7M |
| Q2 2021 | 40 | $69.3M |
| Q1 2021 | 50 | $134.0M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Protara Therapeutics, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Opaleye Management Inc. | 2,692,594 | $8.08M | 2.42% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 793,558 | $2.48M | 0.05% | −37,083−4.5% | Reduced |
| Vanguard Group Inc | 427,612 | $1.34M | 0.00% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 290,051 | $907.9K | 0.03% | 00.0% | Unchanged |
| Boxer Capital, LLC | 209,227 | $655.0K | 0.03% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 199,671 | $625.0K | 0.00% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 188,664 | $584.9K | 0.24% | 00.0% | Unchanged |
| Privium Fund Management (UK) Ltd | 119,730 | $401.1K | 0.32% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 83,420 | $258.6K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 64,000 | $198.4K | 0.01% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 58,906 | $184.0K | 0.00% | −8,094−12.1% | Reduced |
| Morgan Stanley | 58,364 | $182.7K | 0.00% | +58,339+233,356.0% | Added |
| Citadel Advisors LLC | 46,187 | $143.2K | 0.00% | +31,339+211.1% | Added |
| BlackRock Inc. | 37,092 | $116.1K | 0.00% | +732+2.0% | Added |
| Two Sigma Investments, LP | 35,745 | $111.9K | 0.00% | −10,402−22.5% | Reduced |
| Two Sigma Advisers, LP | 31,618 | $99.0K | 0.00% | −15,600−33.0% | Reduced |
| State Street Corp | 30,900 | $95.8K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 26,321 | $82.0K | 0.00% | −3,305−11.2% | Reduced |
| Northern Trust Corp | 20,587 | $64.4K | 0.00% | +568+2.8% | Added |
| Boothbay Fund Management, LLC | 18,864 | $59.0K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 17,907 | $56.0K | 0.00% | 00.0% | Unchanged |
| Assenagon Asset Management S.A. | 17,336 | $54.3K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 16,834 | $52.2K | 0.00% | 00.0% | Unchanged |
| LPL Financial LLC | 10,025 | $31.4K | 0.00% | +10,025 | New |
| Acadian Asset Management LLC | 6,314 | $19.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 971 | $3.04K | 0.00% | −1,329−57.8% | Reduced |
| Wells Fargo & Company | 560 | $1.75K | 0.00% | +1+0.2% | Added |
| Advisor Group Holdings, Inc. | 100 | $313 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 100 | $0 | 0.00% | +100 | New |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −124−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −22−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −133−100.0% | Sold out |